BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32794031)

  • 1. Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels.
    Yang L; Lu D; Lai Y; Shen M; Yu Q; Lei T; Pu T; Bu H
    Ann Surg Oncol; 2021 Feb; 28(2):975-984. PubMed ID: 32794031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
    Choi DX; Eaton AA; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2013 Apr; 20(4):1302-10. PubMed ID: 23161115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.
    Muhsen S; Barrio AV; Miller M; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2017 Dec; 24(13):3888-3895. PubMed ID: 28828599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial.
    Strell C; Folkvaljon D; Holmberg E; Schiza A; Thurfjell V; Karlsson P; Bergh J; Bremer T; Akslen LA; Wärnberg F; Östman A
    Clin Cancer Res; 2021 Jun; 27(12):3469-3477. PubMed ID: 33952629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
    Solin LJ; Gray R; Hughes LL; Wood WC; Lowen MA; Badve SS; Baehner FL; Ingle JN; Perez EA; Recht A; Sparano JA; Davidson NE
    J Clin Oncol; 2015 Nov; 33(33):3938-44. PubMed ID: 26371148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
    Solin LJ; Gray R; Baehner FL; Butler SM; Hughes LL; Yoshizawa C; Cherbavaz DB; Shak S; Page DL; Sledge GW; Davidson NE; Ingle JN; Perez EA; Wood WC; Sparano JA; Badve S
    J Natl Cancer Inst; 2013 May; 105(10):701-10. PubMed ID: 23641039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy.
    Yang L; Shen M; Qiu Y; Tang T; Bu H
    Breast; 2022 Aug; 64():1-6. PubMed ID: 35462343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Biological Signature for Breast Ductal Carcinoma
    Bremer T; Whitworth PW; Patel R; Savala J; Barry T; Lyle S; Leesman G; Linke SP; Jirström K; Zhou W; Amini RM; Wärnberg F
    Clin Cancer Res; 2018 Dec; 24(23):5895-5901. PubMed ID: 30054280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.
    Schiza A; Thurfjell V; Stenmark Tullberg A; Olofsson H; Lindberg A; Holmberg E; Bremer T; Micke P; Karlsson P; Wärnberg F; Strell C
    Eur J Cancer; 2022 Jun; 168():128-137. PubMed ID: 35236568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
    Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
    Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
    Corradini S; Pazos M; Schönecker S; Reitz D; Niyazi M; Ganswindt U; Schrodi S; Braun M; Pölcher M; Mahner S; Harbeck N; Engel J; Belka C
    Radiat Oncol; 2018 Feb; 13(1):25. PubMed ID: 29426355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.
    Raldow AC; Sher D; Chen AB; Recht A; Punglia RS
    J Clin Oncol; 2016 Nov; 34(33):3963-3968. PubMed ID: 27621393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial.
    Thorat MA; Levey PM; Jones JL; Pinder SE; Bundred NJ; Fentiman IS; Cuzick J
    Clin Cancer Res; 2021 Oct; 27(19):5317-5324. PubMed ID: 34380636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast.
    Lazzeroni M; DeCensi A; Guerrieri-Gonzaga A; Pagan E; Bagnardi V; Macis D; Serrano D; Vingiani A; Bonizzi G; Barberis M; Pruneri G; Wagner S; Gandini S; Viale G; Bonanni B
    Mod Pathol; 2020 Jun; 33(6):1065-1077. PubMed ID: 31925342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ.
    Guerini-Rocco E; Bellerba F; Concardi A; Taormina SV; Cammarata G; Fumagalli C; Guerrieri-Gonzaga A; Macis D; Del Fiol Manna E; Balladore E; Cannone M; Veronesi P; Fusco N; Bonanni B; Viale G; Barberis M; Gandini S; Lazzeroni M
    Eur J Cancer; 2024 May; 203():114063. PubMed ID: 38615592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: A meta-analysis of randomized controlled trials.
    Garg PK; Jakhetiya A; Pandey R; Chishi N; Pandey D
    Breast J; 2018 May; 24(3):233-239. PubMed ID: 28833776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates in the treatment of ductal carcinoma in situ of the breast.
    Lebeau A; Kühn T
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):49-58. PubMed ID: 26694830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative radiotherapy after DCIS: Useful for whom?
    Karlsson P
    Breast; 2017 Aug; 34 Suppl 1():S43-S46. PubMed ID: 28663003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.